The study suggested that high oxytocin receptor levels are associated with increased EGF sensitivity and that oxytocin receptors promote EGF-stimulated RSK activation via the mTOR pathway, leading to downstream rpS6 activation and enhanced migration of breast cancer cells. The gene discussed is EGF; the disease is breast cancer.